Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
暂无分享,去创建一个
H. Tumani | M. Otto | J. Brettschneider | M. Senel | F. Lauda | S. Presslauer | Rehaneh Mojib-Yezdani
[1] A. Petzold. Intrathecal oligoclonal IgG synthesis in multiple sclerosis , 2013, Journal of Neuroimmunology.
[2] E. Meinl,et al. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis , 2013, Nature Reviews Neurology.
[3] U. Rot,et al. Comparison of two methods for the detection of oligoclonal bands in a large number of clinically isolated syndrome and multiple sclerosis patients , 2012, Clinical Neurology and Neurosurgery.
[4] H. Hartung,et al. Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis , 2011, Annals of neurology.
[5] M. Krumbholz,et al. Humoral autoimmunity in multiple sclerosis , 2011, Journal of the Neurological Sciences.
[6] B. Sela,et al. Immunoglobulin Free Light Chain Dimers in Human Diseases , 2011, TheScientificWorldJournal.
[7] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[8] A. Moulignier,et al. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event , 2011, Multiple sclerosis.
[9] B. Sela,et al. Free light chain monomers in the diagnosis of multiple sclerosis , 2010, Journal of Neuroimmunology.
[10] J. Álvarez-cermeño,et al. The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands , 2010, Journal of Neuroimmunology.
[11] J. Kassubek,et al. The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS) , 2010, PloS one.
[12] M. Mühlau,et al. The radiologically isolated syndrome: take action when the unexpected is uncovered? , 2010, Journal of Neurology.
[13] À. Rovira,et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. , 2010, Brain : a journal of neurology.
[14] A. Ludolph,et al. The chemokine CXCL13 in acute neuroborreliosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[15] J. Fleming,et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.
[16] A. Ludolph,et al. IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome , 2009, PloS one.
[17] D. Goodin,et al. Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode , 2009, Multiple sclerosis.
[18] H. Hartung,et al. Cerebrospinal fluid biomarkers in multiple sclerosis , 2009, Neurobiology of Disease.
[19] F. Birklein,et al. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid , 2009, Acta neurologica Scandinavica.
[20] T. Brücke,et al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis , 2008, Journal of Neurology.
[21] A. Rovira,et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? , 2008, Neurology.
[22] Francesco Lolli,et al. Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection. , 2007, Clinical chemistry.
[23] B. Thrower. Clinically isolated syndromes , 2007, Neurology.
[24] G. Giovannoni. Multiple Sclerosis Cerebrospinal Fluid Biomarkers , 2006, Disease markers.
[25] H. Link,et al. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness , 2006, Journal of Neuroimmunology.
[26] M. Krumbholz,et al. B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation , 2006, Annals of neurology.
[27] A. Kraneveld,et al. Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases. , 2006, European journal of pharmacology.
[28] D. Bernard,et al. Quantification of Immunoglobulin Free Light Chains in CerebroSpinal Fluid by Nephelometry , 2005, Journal of Clinical Immunology.
[29] K. Lackner,et al. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. , 2004, Clinical chemistry.
[30] L. Benson,et al. Trimolecular Complexes of λ Light Chain Dimers in Serum of a Patient with Multiple Myeloma , 2002 .
[31] M. Drayson,et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. , 2001, Clinical chemistry.
[32] Hansotto Reiber,et al. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs , 2001, Journal of the Neurological Sciences.
[33] Hansotto Reiber,et al. Reporting Cerebrospinal Fluid Data: Knowledge Base and Interpretation Software , 2001, Clinical chemistry and laboratory medicine.
[34] M. Krakauer,et al. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis , 1998, Acta neurologica Scandinavica.
[35] G. Comi,et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.
[36] K. Lamers,et al. Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: qualitative and quantitative measurements , 1995, Journal of Neuroimmunology.
[37] G. Bernardi,et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[38] R. Newcombe. Confidence intervals: enlightening or mystifying? , 1992, BMJ.
[39] E. Thompson,et al. Isoelectric Focusing of Cerebrospinal Fluid Immunoglobulin G: An Annotated Update , 1990, Annals of clinical biochemistry.
[40] R. Rudick,et al. Relative diagnostic value of cerebrospinal fluid kappa chains in MS , 1989, Neurology.
[41] C. Laterre,et al. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases , 1988, Journal of Neuroimmunology.
[42] C. DeCarli,et al. Free light chains in multiple sclerosis and infections of the CNS , 1987, Neurology.
[43] J. E. Hopper,et al. Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. , 1986, Cellular immunology.
[44] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[45] K. Felgenhauer,et al. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system , 1976, Journal of the Neurological Sciences.
[46] L. Benson,et al. Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma. , 2002, Clinical chemistry.
[47] A. Solomon,et al. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. , 1998, Clinical and experimental immunology.